Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C McCloskey

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Biomaterials Research|October 4, 2024
Pericytes Enrich the Basement Membrane and Reduce Neutrophil Transmigration in an In Vitro Model of Peripheral Inflammation at the Blood-Brain BarrierMolly C McCloskey, S Danial Ahmad, Louis P Widom, et al.
Journal of Medicinal Chemistry|February 18, 2005
CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonistBruce M Baron, Robert J Cregge, Robert A Farr, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2017
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosisJoachim Müller, Adriana Aguado-Martínez, Luis-Miguel Ortega-Mora, et al.
Current Research in Toxicology|February 13, 2025
An automated platform for simultaneous, longitudinal analysis of engineered neuromuscular tissues for applications in neurotoxin potency testingJacob W Fleming, Molly C McCloskey, Kevin Gray, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
European Journal of Pharmacology|April 4, 1997
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonistB M Baron, B L Harrison, J H Kehne, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvumWenlin Huang, Ryan Choi, Matthew A Hulverson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profileJ H Kehne, B M Baron, A A Carr, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Biomaterials Research|October 4, 2024
Pericytes Enrich the Basement Membrane and Reduce Neutrophil Transmigration in an In Vitro Model of Peripheral Inflammation at the Blood-Brain BarrierMolly C McCloskey, S Danial Ahmad, Louis P Widom, et al.
Journal of Medicinal Chemistry|February 18, 2005
CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonistBruce M Baron, Robert J Cregge, Robert A Farr, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2017
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosisJoachim Müller, Adriana Aguado-Martínez, Luis-Miguel Ortega-Mora, et al.
Current Research in Toxicology|February 13, 2025
An automated platform for simultaneous, longitudinal analysis of engineered neuromuscular tissues for applications in neurotoxin potency testingJacob W Fleming, Molly C McCloskey, Kevin Gray, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
European Journal of Pharmacology|April 4, 1997
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonistB M Baron, B L Harrison, J H Kehne, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvumWenlin Huang, Ryan Choi, Matthew A Hulverson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profileJ H Kehne, B M Baron, A A Carr, et al.
Pageof 11